Literature DB >> 20044637

A novel strategy by cryoablation for advanced hepatoma.

Shinji Osada1, Kazuhiro Yoshida, Shigetoyo Saji.   

Abstract

Ablative techniques have been developed against advanced liver cancer in cases where surgical resection is impossible. Among the ablation procedures used, thermal ablation therapy is widely applied, and the safety and efficacy of this technique in controlling local progression of cancer have been well characterized. However, the principle of cryosurgery is not only to control local recurrence, but also to stimulate the immune system into initiating an antitumor response. In recent years, we have used a liquid nitrogen-based cryogenic procedure and developed a treatment method for patients with unresectable liver tumors. Following this, repeated treatment was demonstrated to induce anticancer immune reaction-related factors. In the present study, a novel strategy as a cryoablation-induced anti-cancer immune reaction is introduced.

Entities:  

Mesh:

Year:  2009        PMID: 20044637

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase.

Authors:  Eric J Sorscher; Jeong S Hong; Paula W Allan; William R Waud; William B Parker
Journal:  Cancer Chemother Pharmacol       Date:  2012-07-04       Impact factor: 3.333

2.  Clinical outcome, proteome kinetics and angiogenic factors in serum after thermoablation of colorectal liver metastases.

Authors:  Marieke W J L A E Wertenbroek; Marianne Schepers; Hannetta J Kamminga-Rasker; Jan T Bottema; Anneke C Muller Kobold; Han Roelofsen; Koert P de Jong
Journal:  BMC Cancer       Date:  2013-05-30       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.